Ketorolac Trometamol S.A.L.F.

Ketorolac Trometamol, the active ingredient in Ketorolac Trometamol S.A.L.F., is a nonsteroidal anti-inflammatory drug (NSAID) presented as an injectable solution for intramuscular and intravenous use. It is employed for short‑term management of moderate to severe acute pain in adult patients.

GNH USA supplies Ketorolac Trometamol S.A.L.F. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Ketorolac Trometamol is an NSAID indicated for short‑term relief of moderate to severe acute pain across several clinical settings. - Post‑operative pain: provides effective analgesia following surgical procedures - Renal colic: reduces pain associated with kidney stone passage - Dental pain: controls discomfort after dental extractions - Musculoskeletal injury: alleviates pain from sprains, strains, and fractures

Ketorolac Trometamol may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Headache - Dizziness - Injection site pain

Serious or Rare Side Effects: - Gastrointestinal bleeding - Severe allergic reaction (anaphylaxis) - Renal impairment

When prescribing Ketorolac Trometamol, clinicians should observe several precautionary measures to minimize risk. - Assess renal function before initiating therapy: avoid use in severe renal impairment. - Avoid in patients with active peptic ulcer disease or gastrointestinal bleeding: increased risk of ulceration. - Use the lowest effective dose for the shortest duration: typically not exceeding five days. - Monitor for signs of bleeding: watch for hematemesis, melena, or bruising. - Avoid concomitant use with other NSAIDs or anticoagulants: heightened risk of adverse events. - Store at ambient temperature: keep in original container, protect from moisture and light.

Ketorolac Trometamol can interact with several medicines, altering its safety profile or efficacy.

Major Interactions (Avoid): - Concurrent use with anticoagulants (e.g., warfarin, heparin): may markedly increase bleeding risk. - Combination with other NSAIDs or COX‑2 inhibitors: can amplify gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - Co‑administration with ACE inhibitors or diuretics: may reduce renal function. - Use with selective serotonin reuptake inhibitors (SSRIs) or serotonin‑norepinephrine reuptake inhibitors (SNRIs): may elevate bleeding tendency. - Concomitant lithium therapy: ketorolac may raise lithium serum concentrations.